Loading
Latest filing published 12 Apr 2013 for CALMARE THERAPEUTICS Inc.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Joel M. Evans in CALMARE THERAPEUTICS Inc. Over a trading history stretching from 24 April 2007 to 21 March 2013, the count stands at 13 filings.
The open-market record is one-sided, with 8 purchases worth €27k and not one sale. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 5 share grants.
A typical purchase (the median) is worth €3,271.
The record was last updated on 12 April 2013 with a share grant in CALMARE THERAPEUTICS Inc. The most recent open-market purchase was published on 22 December 2011, 5,420 days ago. Filings reach the SEC (Form 4) feed a median of 6 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations